论文信息 - Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5–11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP) - 字舞流文

Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5–11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP)

A. Licari | G. Marseglia | M. M. del Giudice | S. Manti | M. Duse | C. Caffarelli | M. Calvani | A. Martelli | F. Cardinale | C. Cravidi | E. Chiappini | G. Ricci | E. Novembre | R. Castagnoli | G. Pingitore | M. Tosca